George Eric Blair received his BSc from the University of Edinburgh and his PhD from the University of Warwick. He did postdoctoral research at the Universities of Aarhus, Denmark, and Uppsala, Sweden. He was a member of the Scientific Staff of the National Institute of Medical Research, London (now the Crick Institute). He is currently a Professor of Molecular and Cellular Biology at the University of Leeds, Leeds, UK. He is a Board member of the Cancer Therapy section of Cancers and a member of the Editorial Board of Tumour Virus Research. His areas of expertise include oncogenic viruses; viral gene therapy; viruses and the immune response; and cancer gene therapy.
George Eric Blair received his BSc from the University of Edinburgh and his PhD from the University of Warwick. He did postdoctoral research at the Universities of Aarhus, Denmark, and Uppsala, Sweden. He was a member of the Scientific Staff of the National Institute of Medical Research, London (now the Crick Institute). He is currently a Professor of Molecular and Cellular Biology at the University of Leeds, Leeds, UK. He is a Board member of the Cancer Therapy section of Cancers and a member of the Editorial Board of Tumour Virus Research. His areas of expertise include oncogenic viruses; viral gene therapy; viruses and the immune response; and cancer gene therapy.